June 2025 - Outages - Outages Lists

general call quality issues in AWS US West today ?
by Izzy Goldstein - TeleGo 01 Jul '25

01 Jul '25

Hiya, At 3:30 PM eastern time several clients reported to us bad call quality on outgoing calls. in our network monitor we see good MOS outgoing to our carrier, our carrier on the other hand sees very poor MOS Was there a known issue today in AWS US West region affecting call quality that anyone else experienced ? -- Izzy Goldstein Chief Technology Officer - DevOps Master Main: (212) 477-1000 x 2085 <(212)%20477-1000> Direct: (929) 477-2085 Website: https://telego.com/ Confidentiality Notice: This e-mail may contain confidential and/or privileged information. If you are not the intended recipient or have received this e-mail in error please notify us immediately by email reply and destroy this e-mail. Any unauthorized copying, disclosure or distribution of the material in this e-mail is strictly forbidden. Any views or opinions presented in this email are solely those of the author and do not necessarily represent those of TeleGo (T). Employees of TeleGo are expressly required not to make defamatory statements and not to infringe or authorize any infringement of copyright or any other legal right by email communications. Any such communication is contrary to TeleGo policy and outside the scope of the employment of the individual concerned. TeleGo will not accept any liability in respect of such communication, and the employee responsible will be personally liable for any damages or other liability arising. TeleGo Hosted PBX <https://youtu.be/DaT8YAZ4V0w>

2 1

DNSExit Seems Down Hard
by David Rubin 22 Jun '25

22 Jun '25

Service we use for some clients for SMTP relay - website seems down - Netdorm - parent company - that website is up. Does anyone have any information or know of a way to reach out to them? -- DR

2 1

Tissue Engineering market 2024 – Industry Growth by 2035
by zoye0583＠gmail.com 19 Jun '25

19 Jun '25

The global tissue engineering market size is projected to grow from USD 4.3 billion in 2024 to USD 12.7 billion by 2035, exhibiting a CAGR of 10.27% during the forecast period. The growing interest of stakeholders in this market is evident from the rise in partnership activity; a major proportion of the deals were signed by companies based in the us Mergers / acquisitions have emerged as the most popular type of partnership model adopted by players engaged in this domain. Additionally, collectively major share was captured by distribution agreements, and product development and commercialization agreements. This trend reflects that companies are continuously striving to expand their existing service offerings as well as launch their proprietary products. It is worth mentioning that the amount presented here is the sum of only those instances for which information was available in the public domain. It is likely that there have been additional funding instances in this market, which have not been reported publicly. Stakeholders have also received financial support in the form of grants to aid the research on tissue engineering-based regenerative products There has been a steep increase in the number of grants awarded, per year. This rise can be attributed to the continuous and commercially viable research being conducted in this domain, which is likely to encourage different non-profit organizations, such as the NIH, to fund diverse initiatives undertaken by various stakeholders. It is worth mentioning that, in 2022, many grants were awarded by NIH. It is worth mentioning that, in 2022, Cleveland Clinic Lerner College of Medicine was awarded the highest grant amount of USD 2.2 million for the project intended for the development of a regulatory factor of cells adhesion in scaffolds. In addition, in 2021 the tissue engineering-based regeneration product developers received million via grants. Considering the rising interest in this domain, it is expected that funding from non-profit organizations will increase in the foreseen future as well. Around 300 patents have been filed / granted for tissue engineering-based regeneration products; both industry and non-industry players are actively involved in such efforts The number of patents filed / granted for tissue engineering-based regeneration products has increased at a steady pace over the years. The growth in intellectual property in this field can be attributed to the continuous research and development efforts being carried out. Specifically, since 2020, many patents have been published across the globe. In recent years, maximum number of patents have been filed with the United States Patent and Trademark Office (USPTO), followed by those filed with the World Intellectual Property Organization (WIPO) and China. Majority of the patents have 9 years left before their expiration, as of 2022. Further, some of the total patents have 9-14 years of their expiration period left. This indicates that majority of the patents filed in this field are recent, and therefore, have considerable time left before their expiration Research Methodology Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Tissue Engineering Market. Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/tissue-engineering-market.html About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way. The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide. Contact: Roots Analysis Sales(a)rootsanalysis.com

3 2

Tissue Engineering market 2024 – Industry Growth by 2035
by zoye0583＠gmail.com 18 Jun '25

18 Jun '25

The global tissue engineering market size is projected to grow from USD 4.3 billion in 2024 to USD 12.7 billion by 2035, exhibiting a CAGR of 10.27% during the forecast period. The growing interest of stakeholders in this market is evident from the rise in partnership activity; a major proportion of the deals were signed by companies based in the us Mergers / acquisitions have emerged as the most popular type of partnership model adopted by players engaged in this domain. Additionally, collectively major share was captured by distribution agreements, and product development and commercialization agreements. This trend reflects that companies are continuously striving to expand their existing service offerings as well as launch their proprietary products. It is worth mentioning that the amount presented here is the sum of only those instances for which information was available in the public domain. It is likely that there have been additional funding instances in this market, which have not been reported publicly. Stakeholders have also received financial support in the form of grants to aid the research on tissue engineering-based regenerative products There has been a steep increase in the number of grants awarded, per year. This rise can be attributed to the continuous and commercially viable research being conducted in this domain, which is likely to encourage different non-profit organizations, such as the NIH, to fund diverse initiatives undertaken by various stakeholders. It is worth mentioning that, in 2022, many grants were awarded by NIH. It is worth mentioning that, in 2022, Cleveland Clinic Lerner College of Medicine was awarded the highest grant amount of USD 2.2 million for the project intended for the development of a regulatory factor of cells adhesion in scaffolds. In addition, in 2021 the tissue engineering-based regeneration product developers received million via grants. Considering the rising interest in this domain, it is expected that funding from non-profit organizations will increase in the foreseen future as well. Around 300 patents have been filed / granted for tissue engineering-based regeneration products; both industry and non-industry players are actively involved in such efforts The number of patents filed / granted for tissue engineering-based regeneration products has increased at a steady pace over the years. The growth in intellectual property in this field can be attributed to the continuous research and development efforts being carried out. Specifically, since 2020, many patents have been published across the globe. In recent years, maximum number of patents have been filed with the United States Patent and Trademark Office (USPTO), followed by those filed with the World Intellectual Property Organization (WIPO) and China. Majority of the patents have 9 years left before their expiration, as of 2022. Further, some of the total patents have 9-14 years of their expiration period left. This indicates that majority of the patents filed in this field are recent, and therefore, have considerable time left before their expiration Research Methodology Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Tissue Engineering Market. Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/tissue-engineering-market.html About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way. The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide. Contact: Roots Analysis Sales(a)rootsanalysis.com

1 0

MS Exchange online NA outage
by vrode＠outages.org 17 Jun '25

17 Jun '25

Does anyone have any further updates? — regards, virendra

2 1

Cloud flare dashboard authentication outage
by Michael Williams 15 Jun '25

15 Jun '25

Trying from USA Mexico and Australia no luck authenticating to cloudflare… using username/password endless verification requests and trying to use SSO shows the below. Error 1101Ray ID: 94ebedcda85447a7 • 2025-06-12 19:59:38 UTCWorker threw exception What happened? You've requested a page on a website (oidc.iam.cfapi.net) that is on the Cloudflare <https://www.cloudflare.com/5xx-error-landing/> network. An unknown error occurred while rendering the page. What can I do? *If you are the owner of this website:* refer to Workers - Errors and Exceptions <https://developers.cloudflare.com/workers/observability/errors/> and check Workers Logs for oidc.iam.cfapi.net. Cloudflare Ray ID: *94ebedcda85447a7*Your IP: Click to revealPerformance & security by Cloudflare <https://www.cloudflare.com/5xx-error-landing> Sent from Gmail Mobile

8 8

Google Cloud Outage
by dan＠comtelus.net 13 Jun '25

13 Jun '25

Seeing reports of issues and now google cloud status page has posted details. https://status.cloud.google.com/

9 8